Skip to main content

COVID-19 vaccines and the pandemic's third year

The U.S. and Europe have shifted their focus toward booster doses, which have been proven critical in protection against omicron. As omicron lays the enduring threat from a mutating coronavirus and new variants, learn the latest developments in the COVID-19 vaccine.

included in this trendline
  • Moderna to seek clearance for COVID-19 vaccine in young children
  • Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill
  • Pfizer, Moderna sued over technology used in COVID vaccines
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.